Founded with the mission to revolutionize pet healthcare, Anivive is a pharmaceutical company that integrates expertise in software development, veterinary medicine, and clinical research to expedite the creation of innovative therapeutics. The company's core vision is to redefine animal health through advanced technology and novel treatments. Anivive focuses on developing vaccines and treatments for conditions such as Valley Fever and Feline Infectious Peritonitis (FIP), targeting the veterinary pharmaceutical market.
Anivive has garnered attention through notable affiliations and partnerships, including collaborations with experts in veterinary science and technology. The company has made significant strides in veterinary medicine, notably advancing the development of a Valley Fever vaccine. Their impact is reflected in their commitment to improving the quality of life for pets, positioning themselves as pioneers in the field of animal health innovation.
